Boryung Stock Forecast for 2023 - 2025 - 2030
Updated on 05/02/2024
Boryung Stock Forecast and Price Target
Boryung's most recent price target of ₩16000.00 for 2024 was provided by two renowned analysts over the past few months, with an average prediction of ₩16000.00. If this prediction is correct, Boryung's stock could rise by 43.5 percent from its current trading price. The potential increase for the stock is ₩16000.00 per share, with a possible range of ₩13000.00 to ₩17000.00. If you're interested in A003850 stock, looking at its competitors might also be a good idea.
43.50% Upside
Boryung Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Boryung's Price has decreased by 100.00%, from ₩9594.48 to ₩0.00. In the next year, analysts predict that Fair Value will reach ₩17.15k – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A128940 Stock Forecast | Hanmi Pharm. | Outperform |
18
|
₩316.50k | Buy/Sell | ₩382.71k | 31.12% |
| A008930 Stock Forecast | Hanmi Science | - |
14
|
₩42.55k | Buy/Sell | ₩0.00 | -100.00% |
| A000250 Stock Forecast | Sam Chun Dang Pharm. | - |
6
|
₩104.60k | Buy/Sell | ₩80.00k | -100.00% |
| A145020 Stock Forecast | Hugel | Buy |
16
|
₩211.50k | Buy/Sell | ₩201.75k | 3.55% |
| A009420 Stock Forecast | Hanall Biopharma | Buy |
14
|
₩36.10k | Buy/Sell | ₩44.67k | 24.65% |
Boryung Revenue Forecast for 2023 - 2025 - 2030
Boryung's Revenue has grown in the last two years, jumping from ₩561.87B to ₩760.48B – an increase of 35.35%. In the next year, analysts predict that Revenue will reach ₩952.00B – an increase of 25.18%. For the next seven years, the forecast is for Revenue to grow by 22.63%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A019170 Stock Forecast | Shinpoong Pharmaceutical Co.,L... | - |
14
|
₩12.96k | Buy/Sell | ₩0.00 | -100.00% |
| A185750 Stock Forecast | Chong Kun Dang Pharmaceutical | Outperform |
16
|
₩104.30k | Buy/Sell | ₩124.29k | 43.82% |
| A069620 Stock Forecast | Daewoong pharmaceutical Co.,Lt... | Buy |
16
|
₩111.90k | Buy/Sell | ₩156.10k | 42.98% |
.jpg)
Boryung Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, Boryung's Dividend per Share has increased by 20.00%, going from ₩83.33 to ₩100.00. According to 2 prominent analysts, Boryung's Dividend per Share will fall by 0.00% in the next year, reaching ₩100.00. By 2030, professionals believe that Boryung's Dividend per Share will decrease by 0.00%, reaching ₩100.00 – a concerning trend for the company.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A005250 Stock Forecast | Green Cross Holdings | - |
16
|
₩16.17k | Buy/Sell | ₩0.00 | -100.00% |
| A003090 Stock Forecast | Daewoong | Outperform |
14
|
₩18.82k | Buy/Sell | ₩38.00k | 32.84% |
| A086450 Stock Forecast | DongKook Pharmaceutical | Buy |
16
|
₩16.48k | Buy/Sell | ₩20.00k | 45.63% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A001060 Stock Forecast | JW Pharmaceutical | Buy |
14
|
₩30.95k | Buy/Sell | ₩40.62k | 35.70% |
| A000640 Stock Forecast | Dong-A Socio Holdings | - |
13
|
₩110.20k | Buy/Sell | ₩0.00 | -100.00% |
| A170900 Stock Forecast | Dong-A ST | Outperform |
17
|
₩67.60k | Buy/Sell | ₩74.50k | 20.56% |
Boryung EBITDA Forecast for 2023 - 2025 - 2030
Boryung's EBITDA has increased by 39.57% In the last two years, going from ₩67.53B to ₩94.25B. In the next year, analysts expect EBITDA to reach ₩128.75B – an increase of 36.61%. For the next seven years, the forecast is for EBITDA to grow by 32.65%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A058820 Stock Forecast | CMG Pharmaceutical | - |
14
|
₩2.24k | Buy/Sell | ₩0.00 | -100.00% |
| A140410 Stock Forecast | Mezzion Pharma | - |
6
|
₩36.55k | Buy/Sell | ₩0.00 | -100.00% |
| A102460 Stock Forecast | REYON Pharmaceutical | - |
15
|
₩15.75k | Buy/Sell | ₩0.00 | -100.00% |
Boryung EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Boryung's EBIT has grown, increasing from ₩39.96B to ₩56.60B – a growth of 41.65%. The next year looks promising for Boryung, with analysts predicting EBIT of ₩85.00B – an increase of 50.17%. Over the next seven years, experts anticipate that Boryung's EBIT will grow at a rate of 48.16%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A047920 Stock Forecast | HLB Pharmaceutical | - |
4
|
₩34.10k | Buy/Sell | ₩0.00 | -100.00% |
| A003000 Stock Forecast | Bukwang Pharmaceutical | - |
10
|
₩6.36k | Buy/Sell | ₩17.66k | -100.00% |
| A249420 Stock Forecast | Ildong Pharmaceutical | Outperform |
12
|
₩15.53k | Buy/Sell | ₩23.00k | 60.98% |
Boryung EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Boryung's EPS has decreased by 100.00%, from ₩460.83 to ₩0.00. In the next year, analysts predict that EPS will reach ₩823.50 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A053030 Stock Forecast | BINEX | - |
16
|
₩14.01k | Buy/Sell | ₩18.00k | -100.00% |
| A007570 Stock Forecast | Ilyang Pharmaceutical Co.,Ltd | - |
13
|
₩14.56k | Buy/Sell | ₩0.00 | -100.00% |
| A243070 Stock Forecast | Huons | Outperform |
18
|
₩34.50k | Buy/Sell | ₩45.00k | 56.52% |
.jpg)